![James Cummings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cummings
Directeur Technique/Scientifique/R&D chez
VAXART, INC.
Fortune : 261 714 $ au 30/06/2026
Profil
Dr. James F.
Cummings, MD, is a Chief Medical Officer at Vaxart, Inc. Dr. Cummings was previously employed as a President & Chief Executive Officer by ICON Government & Public Health Solutions, Inc., a VP-Clinical Development & Translational Medicine by Novavax, Inc., a Director-Defense Department by Global Emerging Infectious Surveillance & Response System, and a Director-Translational Medicine by Walter Reed Army Institute of Research.
He also served on the board at OyaGen, Inc. He received his undergraduate degree from Georgetown University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXART, INC. 0,18% | 26/05/2026 | 432 585 ( 0,18% ) | 261 714 $ | 30/06/2026 |
Postes actifs de James Cummings
| Sociétés | Poste | Début |
|---|---|---|
| VAXART, INC. | Directeur Technique/Scientifique/R&D | 27/09/2021 |
Anciens postes connus de James Cummings
| Sociétés | Poste | Fin |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Directeur Général | 01/09/2021 |
| NOVAVAX, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01/08/2015 |
Walter Reed Army Institute of Research | Corporate Officer/Principal | 01/03/2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Directeur/Membre du Conseil | - |
Formation de James Cummings
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Commercial Services |
Walter Reed Army Institute of Research | Electronic Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Global Emerging Infectious Surveillance & Response System |
